Sweetwater Hospital Association has received a large quantity of Johnson and Johnson COVID-19 vaccines and will be hosting a mass drive-through vaccination clinic THIS SATURDAY, March 13, 2021 from 9am-5pm at Sweetwater High School. THE VACCINES WILL BE FIRST COME, FIRST SERVE SO NO APPOINTMENT IS NECESSARY. If possible, please print off the Vaccine Consent Form and have it filled out to give to the SHA Staff prior to driving through.
WHAT: MASS COVID-19 VACCINATION CLINIC
TIME: March 13, 2021- 9:00am to 5:00pm
WHERE: Sweetwater High School (414 S High St, Sweetwater, TN 37874)
WHAT TO BRING:
1. THIS CONSENT FORM (click here->Vaccine Consent Form)- Please have this filled out and ready to give to our staff
2. A valid driver’s license or state ID
3. An Insurance Card (NOT required)
1. If you have previously received a Moderna or Pfizer Vaccine, you cannot use the Johnson and Johnson as your second dose.
2. You must wait at least 2 weeks to receive the COVID-19 vaccine if you have received any other vaccine.
3. You must wait at least 90 days after receiving a dose of the monoclonal antibody.
The criteria for the vaccine is the CDC risk based phases- 1a1, 1a2, 1b, 1c, AND anyone who is 65 and older:
- People aged 65—74 years because they are at high risk of hospitalization, illness, and death from COVID-19. People aged 65—74 years who are also residents of long-term care facilities should be offered vaccination in Phase 1a.
- People aged 16—64 years with underlying medical conditions which increase the risk of serious, life-threatening complications from COVID-19.
- Please note: The Johnson and Johnson and Moderna vaccines are recommended to individuals 18 years and older.
- Other essential workers, such as people who work in transportation and logistics, food service, housing construction and finance, information technology, communications, energy, law, media, public safety, and public health.
Examples of underlying medical conditions include BUT ARE NOT LIMITED TO:
- Chronic kidney disease
- COPD (chronic obstructive pulmonary disease)
- Down Syndrome
- Heart conditions, such as heart failure, coronary artery disease, or cardiomyopathies
- Immunocompromised state (weakened immune system) from solid organ transplant
- Obesity (body mass index [BMI] of 30 kg/m2 or higher but < 40 kg/m2)
- Severe Obesity (BMI ≥ 40 kg/m2)
- Pregnancy or people living with pregnant people
- Sickle cell disease
- Type 1 OR Type 2 diabetes mellitus
- Asthma (moderate-to-severe)
- Cerebrovascular disease (affects blood vessels and blood supply to the brain)
- Cystic fibrosis
- Hypertension or high blood pressure
- Immunocompromised state (weakened immune system) from blood or bone marrow transplant, immune deficiencies, HIV, use of corticosteroids, or use of other immune weakening medicines
- Neurologic conditions, such as dementia
- Liver disease
- Overweight (BMI > 25 kg/m2, but < 30 kg/m2)
- Pulmonary fibrosis (having damaged or scarred lung tissues)
- Thalassemia (a type of blood disorder)
Please Note: The above list of underlying medical conditions is not exhaustive and only includes conditions with sufficient evidence to draw conclusions; it is a living document that may be updated at any time, subject to potentially rapid change as the science evolves. This list is meant to inform clinicians to help them provide the best care possible for patients, and to inform individuals about their level of risk so they can make individual decisions about illness prevention. Notably, the list may not include every condition that might increase one’s risk for developing severe illness from COVID-19, such as those for which evidence may be limited (e.g., rare conditions). Individuals with any underlying medical condition (including those conditions that are NOT on the current list) should consult with their healthcare providers about personal risk factors and circumstances to determine whether extra precautions are warranted.